In vitro activity of ceftobiprole against Acinetobacter baumannii clinical isolates

International Journal of Antimicrobial Agents

Volumn 34, Issue 3, 2009, Pages 265-267

  Marti, Sara ^a   Sánchez Céspedes, Javier ^a   Espinal, Paula ^a   Vila, Jordi ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

Acinetobacter spp.; Ceftobiprole; Susceptibility

Indexed keywords

CEFEPIME; CEFTAZIDIME; CEFTOBIPROLE;

ACINETOBACTER BAUMANNII; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; CONTROLLED STUDY; GENE EXPRESSION; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANTI-BACTERIAL AGENTS; CEFTAZIDIME; CEPHALOSPORINS; GENE EXPRESSION; GENES, BACTERIAL; HUMANS; INTENSIVE CARE UNITS; MICROBIAL SENSITIVITY TESTS; PNEUMONIA, VENTILATOR-ASSOCIATED;

EID: 67651014849     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2009.03.015     Document Type: Article

References (12)

1. Bergogne-Bérézin E., and Towner K.J. Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin Microbiol Rev 9 (1996) 148-165
2. Vila J., Martí S., and Sánchez-Céspedes J. Porins, efflux pumps and multidrug resistance in Acinetobacter baumannii. J Antimicrob Chemother 59 (2007) 1210-1215
3. Poirel L., and Nordmann P. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. Clin Microbiol Infect 12 (2006) 826-836
4. Yun H.C., Ellis M.W., and Jorgensen J.H. Activity of ceftobiprole against community-associated methicillin-resistant Staphylococcus aureus isolates recently recovered from US military trainees. Diagn Microbiol Infect Dis 59 (2007) 463-466
5. Chambers H.F. Ceftobiprole: in-vivo profile of a bactericidal cephalosporin. Clin Microbiol Infect 12 (2006) 17-22
6. Noel G.J. Clinical profile of ceftobiprole, a novel β-lactam antibiotic. Clin Microbiol Infect 13 Suppl. 2 (2007) 25-29
7. Davies T.A., Page M.G., Shang W., Andrew T., Kania M., and Bush K. Binding of ceftobiprole and comparators to the penicillin-binding proteins of Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, and Streptococcus pneumoniae. Antimicrob Agents Chemother 51 (2007) 2621-2624
8. Denis O., Deplano A., Nonhoff C., Hallin M., De Ryck R., Vanhoof R., et al. In vitro activities of ceftobiprole, tigecycline, daptomycin and 19 other antimicrobials against methicillin-resistant Staphylococcus aureus strains from a national survey of Belgian hospitals. Antimicrob Agents Chemother 50 (2006) 2680-2685
9. Queenan A.M., Shang W., Kania M., Page M.G., and Bush K. Interactions of ceftobiprole with β-lactamases from molecular classes A to D. Antimicrob Agents Chemother 51 (2007) 3089-3095
10. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Seventeenth informational supplement. Document M100-S17. Wayne, PA: CLSI; 2008.
11. Navia M., Ruiz J., and Vila J. Characterization of an integron carrying a new class D β-lactamase (OXA-37) in Acinetobacter baumannii. Microb Drug Resist 8 (2002) 261-266
12. Aba1 in epidemiologically unrelated Acinetobacter baumannii clinical isolates. FEMS Microbiol Lett 274 (2007) 63-66